Literature DB >> 15885497

A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.

Kayvan Zainabadi1, Payam Benyamini, Rita Chakrabarti, Mysore S Veena, Settara C Chandrasekharappa, Richard A Gatti, Eri S Srivatsan.   

Abstract

Nonrandom deletion of chromosome 11q13 sequences is a significant event in a number of human tumors. We have recently identified a 300-kb minimal area of deletion in primary cervical tumors that overlaps with deletions observed in endocrine and nasopharyngeal tumors. We have also observed a 5.7-kb homozygous deletion within this interval in HeLa cells (a cervical cancer cell line), HeLa cell-derived tumorigenic hybrids, and a primary cervical tumor, suggesting the presence of a tumor suppressor gene in this region. In the present investigation, we have constructed a 700-kb contig map encompassing the 300-kb deletion using the human genome sequence database and confirmed the map using various STS markers from the region. Our map also shows the overlap of a previously published rare, heritable fragile site, FRA11A, with the cervical cancer deletion locus. The mapped region contains highly repetitive GC-poor sequences. We have identified and characterized eight different polymorphic microsatellite markers from the sequences within and surrounding the deletion. Further, expression studies performed with 18 different ESTs localized adjacent to the homozygous deletion showed the presence of a transcript for only one of the ESTs, AA282789. This EST mapping within the homozygous deletion is also expressed in HeLa cells, thereby excluding the EST as the putative tumor suppressor gene. Additionally, analysis of four candidate genes (SF3B2, BRMS1, RIN1, and RAB1B) from the region showed expression of the expected size message in both the nontumorigenic and the tumorigenic HeLa cell hybrids, thereby excluding them as the putative tumor suppressor gene(s). However, Northern blot analysis with a fifth candidate gene, PACS1 (phosphofurin acidic cluster sorting protein), mapped to the deletion/FRA11A overlap region showed the expression of an 8-kb transcript in HeLa and five other tumor cell lines in addition to the expected 4.5-kb transcript. Since the gene shows abundant expression in normal tissues and an altered transcript is observed in tumor cell lines, we hypothesize that this gene could represent sequences of the putative tumor suppressor gene. Finally, we have observed a perfect 48-bp CAG/CCG repeat 99 kb proximal to D11S913, the marker linked to the neurodegenerative disorder spinocerebellar ataxia 5. The physical and transcription maps and the microsatellite markers of the 700-kb region of chromosome 11q13 should be helpful in the cloning of the cervical cancer tumor suppressor gene.

Entities:  

Mesh:

Year:  2005        PMID: 15885497     DOI: 10.1016/j.ygeno.2005.02.014

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization.

Authors:  Daniella Brasacchio; Amber E Alsop; Tahereh Noori; Mariam Lufti; Sweta Iyer; Kaylene J Simpson; Phillip I Bird; Ruth M Kluck; Ricky W Johnstone; Joseph A Trapani
Journal:  Cell Death Differ       Date:  2017-01-06       Impact factor: 15.828

2.  RIN1 exhibits oncogenic property to suppress apoptosis and its aberrant accumulation associates with poor prognosis in melanoma.

Authors:  Ping Fang; Zigang Zhao; Hongfang Tian; Xin Zhang
Journal:  Tumour Biol       Date:  2012-05-25

3.  One in four individuals of African-American ancestry harbors a 5.5kb deletion at chromosome 11q13.1.

Authors:  Kayvan Zainabadi; Anuja V Jain; Frank X Donovan; David Elashoff; Nagesh P Rao; Vundavalli V Murty; Settara C Chandrasekharappa; Eri S Srivatsan
Journal:  Genomics       Date:  2014-01-10       Impact factor: 5.736

4.  Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.

Authors:  J Li; Y Cheng; D Tai; M Martinka; D R Welch; G Li
Journal:  Oncogene       Date:  2010-10-11       Impact factor: 9.867

5.  Cell proliferation and epidermal growth factor signaling in non-small cell lung adenocarcinoma cell lines are dependent on Rin1.

Authors:  Jin C Tomshine; Sandra R Severson; Dennis A Wigle; Zhifu Sun; Daniah A T Beleford; Vijayalakshmi Shridhar; Bruce F Horazdovsky
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

6.  Inactivation of the cystatin E/M tumor suppressor gene in cervical cancer.

Authors:  Mysore S Veena; Grant Lee; Daniel Keppler; Marc S Mendonca; J Leslie Redpath; Eric J Stanbridge; Sharon P Wilczynski; Eri S Srivatsan
Journal:  Genes Chromosomes Cancer       Date:  2008-09       Impact factor: 5.006

7.  Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.

Authors:  Mysore S Veena; Santanu Raychaudhuri; Saroj K Basak; Natarajan Venkatesan; Parameet Kumar; Roopa Biswas; Rita Chakrabarti; Jing Lu; Trent Su; Marcus Gallagher-Jones; Marco Morselli; Haiqing Fu; Matteo Pellegrini; Theodore Goldstein; Mirit I Aladjem; Matthew B Rettig; Sharon P Wilczynski; Daniel Sanghoon Shin; Eri S Srivatsan
Journal:  J Biol Chem       Date:  2020-10-07       Impact factor: 5.157

Review 8.  At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis.

Authors:  Robert T Youker; Ujwal Shinde; Robert Day; Gary Thomas
Journal:  Biochem J       Date:  2009-06-12       Impact factor: 3.857

9.  High RIN1 expression is associated with poor prognosis in patients with gastric adenocarcinoma.

Authors:  Hai-Feng Yu; Gang Zhao; Zhi-Jun Ge; Dao-Rong Wang; Jie Chen; Yun Zhang; Tian-Zhou Zha; Kai Zhang; Miao Zhang; Yong-Fei Tan; Su-Jun Zhou; Chao Jiang
Journal:  Tumour Biol       Date:  2012-05-06

10.  Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression.

Authors:  Yanhua Wu; Wenjun Jiang; Yingming Wang; Jun Wu; Hexige Saiyin; Xiaojing Qiao; Xinyu Mei; Bin Guo; Xiao Fang; Lu Zhang; Huiling Lou; Chaoqun Wu; Shouyi Qiao
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.